MOLECULAR PROFILING OF P53 MUTANT ENDOMETRIAL CANCER REVEALS DISTINCT SUBGROUPS WITH OPPORTUNITIES FOR PERSONALIZED THERAPEUTIC APPROACHES

被引：0

作者：

Blanc-Durand, Felix ^{[1
]}

Kramer, Claire J. H. ^{[2
,3
]}

Rouleau, Etienne ^{[4
]}

Vasseur, Antoine ^{[4
]}

Bosse, Tjalling ^{[5
]}

De Boer, Stephanie ^{[6
]}

Edmondson, Richard ^{[7
]}

Powell, Melanie ^{[8
]}

Crosbie, Emma ^{[7
]}

Singh, Naveena ^{[9
]}

Mcalpine, Jessica ^{[9
]}

Mackay, Helen ^{[10
]}

Pollock, Pamela ^{[11
]}

Mileshkin, Linda ^{[12
]}

Scott, Clare ^{[13
]}

Lim, Yi Wan ^{[14
]}

Lim, Siew Eng ^{[15
]}

Ngoi, Natalie Yan Li ^{[14
]}

Tan, David ^{[15
]}

Leary, Alexandra ^{[1
]}

机构：

[1] Inst Gustave Roussy, Med Oncol, Villejuif, France

[2] Leiden Univ, Med Ctr, Leiden, Netherlands

[3] DGOG, Dept Pathol, Leiden, Netherlands

[4] Inst Gustave Roussy, Canc Biol, Villejuif, France

[5] Leids Univ Med Ctr LUMC, Dept Pathol, Leiden, Netherlands

[6] Leiden Univ Med Ctr, Radiat Oncol, Leiden, Netherlands

[7] Manchester Acad Hlth Sci Ctr, Med Oncol, Manchester, Lancs, England

[8] St Bartholomews Hosp, Med Oncol, London, England

[9] Vancouver Gen Hosp, Pathol, Vancouver, BC, Canada

[10] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Med Oncol, Toronto, ON, Canada

[11] Queenslans Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia

[12] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia

[13] Walter & Eliza Hall Med Res Inst, Clin Translat Ctr, Melbourne, Vic, Australia

[14] Natl Univ Canc Inst, Med Oncol, Singapore, Singapore

[15] Natl Univ Canc Inst Singapore, Dept Haematol Oncol, Singapore, Singapore

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷 / SUPPL_4期

关键词：

D O I：

10.1136/ijgc-2023-IGCS.66

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PR024

引用

页码：A44 / A44

页数：1

共 50 条

[41] Distinct expression and function of breast cancer metastasis suppressor 1 in mutant P53 glioblastoma
Babu, Deepak
Chintal, Ramulu
Panigrahi, Manas
Phanithi, Prakash Babu
CELLULAR ONCOLOGY, 2022, 45 (06) : 1451 - 1465
[42] Restoring p53 Function in Cancer: Novel Therapeutic Approaches for Applying the Brakes to Tumorigenesis
Di Cintio, Alessandra
Di Gennaro, Elena
Budillon, Alfredo
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2010, 5 (01) : 1 - 13
[43] MOLECULAR GENETIC AND IMMUNOCHEMICAL ANALYSIS OF MUTANT P53 IN HUMAN OVARIAN-CANCER
CHANG, K
DING, I
KERN, FG
WILLINGHAM, MC
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1991, 39 (05) : 728 - 728
[44] Curcumin mediates selective aggregation of mutant p53 in cancer cells: A promising therapeutic strategy
Oak, Swapnil
Karajgikar, Onkar
Teni, Tanuja
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 677 : 141 - 148
[45] Novel miRNA-based therapeutic approach to selectively target mutant p53 in cancer
Lulla, Amriti R.
Einarson, Margret B.
Zhou, Yan
Dicker, David T.
El-Deiry, Wafik S.
CANCER RESEARCH, 2017, 77
[46] KIFC1 as a novel therapeutic target for p53 mutant colorectal cancer.
Mittal, Karuna
Wei, Guanhao
Kaur, Jaspreet
Choi, Da Hoon
Reid, Michelle D.
Rida, Padmashree C. G.
Aneja, Ritu
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[47] Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides
Tal, Perry
Eizenberger, Shay
Cohen, Elad
Goldfinger, Naomi
Pietrokovski, Shmuel
Oren, Moshe
Rotter, Varda
ONCOTARGET, 2016, 7 (11) : 11817 - 11837
[48] Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGγ
Wang, Huihui
Bao, Wei
Jiang, Feizhou
Che, Qi
Chen, Zheng
Wang, Fangyuan
Tong, Huan
Dai, Chenyun
He, Xiaoying
Liao, Yun
Liu, Binya
Sun, Jing
Wan, Xiaoping
CANCER LETTERS, 2015, 360 (02) : 269 - 279
[49] p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial
Vermij, Lisa
Leon-Castillo, Alicia
Singh, Naveena
Powell, Melanie E.
Edmondson, Richard J.
Genestie, Catherine
Khaw, Pearly
Pyman, Jan
McLachlin, C. Meg
Ghatage, Prafull
de Boer, Stephanie M.
Nijman, Hans W.
Smit, Vincent T. H. B. M.
Crosbie, Emma J.
Leary, Alexandra
Creutzberg, Carien L.
Horeweg, Nanda
Bosse, Tjalling
MODERN PATHOLOGY, 2022, 35 (10) : 1475 - 1483
[50] Mutant p53 protein in serum could be used as a molecular marker in human breast cancer
Balogh, GA
Mailo, DA
Corte, MM
Roncoroni, P
Nardi, H
Vincent, E
Martinez, D
Cafasso, ME
Frizza, A
Ponce, G
Vincent, E
Barutta, E
Lizarraga, P
Lizarraga, G
Monti, C
Paolillo, E
Vincent, R
Quatroquio, R
Grimi, C
Maturi, H
Aimale, M
Spinsanti, C
Montero, H
Santiago, J
Shulman, L
Rivadulla, M
Machiavelli, M
Salum, G
Cuevas, MA
Picolini, J
Gentili, A
Gentili, R
Mordoh, J
INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 28 (04) : 995 - 1002

← 1 2 3 4 5 →